Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.
about
Lipid phosphate phosphatase (LPP3) and vascular developmentIncreased expression of angiogenic genes in the brains of mouse meg3-null embryosMaternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampusTranscriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions.Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid.Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cellsAssociation of lipid metabolism with ovarian cancerExpression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression.The impact of KRAS mutations on VEGF-A production and tumour vascular networkLysophosphatidic acid in vascular development and diseaseZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast CancerLysophosphatidic acid-induced p21Waf1 expression mediates the cytostatic response of breast and ovarian cancer cells to TGFβ.Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma.Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer CellsHyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer.Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.miRNA profiling along tumour progression in ovarian carcinomaEffect of ART1 on the proliferation and migration of mouse colon carcinoma CT26 cells in vivo.Lysophosphatidic acid signaling in ovarian cancer.The Unique Molecular and Cellular Microenvironment of Ovarian CancerInhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29.Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolaseToxicity of doxorubicin on pig liver after chemoembolization with doxorubicin-loaded microspheres: a pilot DNA-microarrays and histology study.Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.The Mammalian Hairless Protein as a DNA Binding Phosphoprotein.Cysteinyl-leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells.
P2860
Q27002640-3212FC7A-3E17-46BD-91C6-A534133E758CQ28590418-C1710898-E795-460B-91C4-1D908EEA7C5AQ30495988-C2AF9AB2-3A88-4591-BE27-725DCFFFEF40Q30763243-580A0183-EA42-4945-B90E-69E78A053CCEQ33585979-065A04DD-88DD-4CAC-9D88-781D5DD8D4B3Q33634483-1D737D87-E1D9-4016-9A56-822D4F2A513CQ33759458-FD8AD5F0-30D7-47DF-BB60-63B5CE18D716Q33809139-4B4B096E-E772-4E41-A3D3-1E6889043C58Q34171997-B2A32DCA-EB6A-4866-AF16-B4FC72C7F294Q34292377-2964C6EE-A293-4669-9A84-153D30CC3C2AQ34503882-C6B58388-A8C6-4582-8AED-6C36C9309CFBQ34626362-145EE39F-1302-45E7-A2F4-E49E558BFB6FQ35018207-77D3A2E0-7197-4720-950A-C7C84156CDD7Q35925156-9DC2B62C-BB83-4835-BE1F-5E8C0992BCD8Q36073708-7CC4B6E0-F345-437B-8CFD-4F4B5D1461D2Q36086891-FE914FAB-B7B1-48A3-B18F-81900ABCB27EQ36127217-1A9DEBDA-E970-4991-8EF0-2D056A270A2FQ36177654-8E68D4C0-E0B7-47D9-A165-35BCE7C705C4Q36393112-56A39581-70F0-4690-91A6-F9D7414EE21BQ36820509-0A06FEE2-AF41-4B1D-B5A4-3A87C8D53688Q37189474-CFD5305A-ECB3-4D43-8F65-781D5E56257FQ37295492-EAF431B8-D68F-4F01-8CBF-03C9239D6E86Q37722089-B39D5F33-10B3-4865-BFBC-04D41647F003Q38590952-9000AE7F-FD3B-4745-BE2C-0D69FE683228Q39169603-E6514F82-CB60-48FD-B6D4-6ED0B83F8D36Q39396280-65347145-2242-4A2A-B511-0A7568FE1B20Q39564371-A1D9F2BC-E71D-4A0E-8B06-4C0DD60D7A29Q40989424-020C9B28-50C1-4053-BEB1-2B31A6785485Q44131322-F5E4D2EB-F721-49BE-A9CB-528F956561DDQ46934145-BF5B4554-F166-4D67-84A4-986A9ADA5588Q47174627-1715E9AA-E5AE-4886-ACDC-CC243272CA50Q48650413-2A11FBB5-9B24-4F9A-B22F-F8452054DFBAQ54629468-E5783F81-76F4-4EE7-A8E4-D78BF0720DF6
P2860
Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Sp-1 and c-Myc mediate lysopho ...... actor-1-independent mechanism.
@en
type
label
Sp-1 and c-Myc mediate lysopho ...... actor-1-independent mechanism.
@en
prefLabel
Sp-1 and c-Myc mediate lysopho ...... actor-1-independent mechanism.
@en
P2093
P2860
P921
P1476
Sp-1 and c-Myc mediate lysopho ...... actor-1-independent mechanism.
@en
P2093
Abir Mukherjee
Regina A Oyesanya
Xianjun Fang
Yuanda Song
Zendra Lee
P2860
P304
P356
10.1158/1078-0432.CCR-08-1945
P407
P577
2009-01-01T00:00:00Z